Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland
The occurrence and genotype–phenotype correlations of the eight most common mutations in the arylsulfatase A (ARSA) gene were studied in 43 unrelated Polish patients suffering from different types of metachromatic leukodystrophy (MLD). Screening for mutations p.R84Q, p.S96F, c.459+1G>A, p.I179S,...
Gespeichert in:
Veröffentlicht in: | Clinical genetics 2005-07, Vol.68 (1), p.48-54 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 54 |
---|---|
container_issue | 1 |
container_start_page | 48 |
container_title | Clinical genetics |
container_volume | 68 |
creator | Ługowska, A Berger, J Tylki-Szymańska, A Löschl, B Molzer, B Zobel, M Czartoryska, B |
description | The occurrence and genotype–phenotype correlations of the eight most common mutations in the arylsulfatase A (ARSA) gene were studied in 43 unrelated Polish patients suffering from different types of metachromatic leukodystrophy (MLD). Screening for mutations p.R84Q, p.S96F, c.459+1G>A, p.I179S, p.A212V, c.1204+1G>A, p.P426L, and c.1401–1411del allowed the identification of 53.5% of the mutant alleles. In the whole investigated group of patients, mutations c.459+1G>A and p.P426L were the most frequent, 19 and 17%, respectively. The prevalence of the third most frequent mutation, i.e. p.I179S (13%), seems to be higher than that in other populations. The incidence of c.1204+1G>A was 5%, which is higher than reported earlier (2%). It seems that p.I179S and c.1204+1G>A are more prevalent in MLD patients from Poland than from other countries. In the group examined by us, mutations p.R84Q, p.S96F, p.A212V, and c.1401–1411del were not detected; thus, 46.5% of MLD alleles remained unidentified. This indicates that other, novel or already described, but rare, mutations exist in Polish population. In late infantile homozygotes for c.459+1G>A and one homozygote for c.1204+1G>A, first clinical symptom was motor deterioration. In adult homozygotes for p.P426L, the disease onset manifested as gait disturbances, followed by choreoathetotic movements, difficulties in swallowing, dysarthria, tremor, and nystagmus. In the carriers of the p.I179S mutation, the hallmark of the clinical picture was psychotic disturbances. |
doi_str_mv | 10.1111/j.1399-0004.2005.00451.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67929072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67929072</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4121-738dbc9240134e09f55b130d612f1b1430af2bdcfce89acd740f4c5687d8ab9d3</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EokvLX0AWEtwS_BE7scQFLSWlaqEHEBISshzH0WabxMFOxObfd7a7tFJ9mfHMM-PxvAhhSlIK58M2pVyphBCSpYwQkYIjaLp7hlYPiedoBUYlikp-gl7FuIUrz4V6iU6oUIKpQq7Qn2vfOTt3JmAz1HjcuMFPy9habDcmGDu50MaptRH7BvduMnYTfG8ggjs33_p6iVPw42bBIwTdMEXcAIBvfAf9ztCLxnTRvT7aU_Tzy_mP9UVy9b38uv50ldiMMprkvKgrq1hGKM8cUY0QFeWklpQ1tKIZJ6ZhVW0b6wplbJ1npMmskEVeF6ZSNT9F7w99x-D_zi5Oum-jdR3M4PwctcwVUyRnAL59Am79HAaYTcMec1JIKQB6c4Tmqne1HkPbm7Do_1sD4N0RMNGarglmsG185GTBOWUZcB8P3L-2c8tjnui9inqr92LpvVj714W-V1Hv9Lo8BwfKk0M5KOB2D-Um3MKHQEn961upy6K8uPwsf-tLfgc5g5-P</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200708665</pqid></control><display><type>article</type><title>Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Ługowska, A ; Berger, J ; Tylki-Szymańska, A ; Löschl, B ; Molzer, B ; Zobel, M ; Czartoryska, B</creator><creatorcontrib>Ługowska, A ; Berger, J ; Tylki-Szymańska, A ; Löschl, B ; Molzer, B ; Zobel, M ; Czartoryska, B</creatorcontrib><description>The occurrence and genotype–phenotype correlations of the eight most common mutations in the arylsulfatase A (ARSA) gene were studied in 43 unrelated Polish patients suffering from different types of metachromatic leukodystrophy (MLD). Screening for mutations p.R84Q, p.S96F, c.459+1G>A, p.I179S, p.A212V, c.1204+1G>A, p.P426L, and c.1401–1411del allowed the identification of 53.5% of the mutant alleles. In the whole investigated group of patients, mutations c.459+1G>A and p.P426L were the most frequent, 19 and 17%, respectively. The prevalence of the third most frequent mutation, i.e. p.I179S (13%), seems to be higher than that in other populations. The incidence of c.1204+1G>A was 5%, which is higher than reported earlier (2%). It seems that p.I179S and c.1204+1G>A are more prevalent in MLD patients from Poland than from other countries. In the group examined by us, mutations p.R84Q, p.S96F, p.A212V, and c.1401–1411del were not detected; thus, 46.5% of MLD alleles remained unidentified. This indicates that other, novel or already described, but rare, mutations exist in Polish population. In late infantile homozygotes for c.459+1G>A and one homozygote for c.1204+1G>A, first clinical symptom was motor deterioration. In adult homozygotes for p.P426L, the disease onset manifested as gait disturbances, followed by choreoathetotic movements, difficulties in swallowing, dysarthria, tremor, and nystagmus. In the carriers of the p.I179S mutation, the hallmark of the clinical picture was psychotic disturbances.</description><identifier>ISSN: 0009-9163</identifier><identifier>EISSN: 1399-0004</identifier><identifier>DOI: 10.1111/j.1399-0004.2005.00451.x</identifier><identifier>PMID: 15952986</identifier><identifier>CODEN: CLGNAY</identifier><language>eng</language><publisher>Oxford, UK; Malden, USA: Blackwell Publishing Ltd/Inc</publisher><subject>Adolescent ; Adult ; Age of Onset ; Alleles ; arylsulfatase A ; Biological and medical sciences ; Cerebroside-Sulfatase - deficiency ; Cerebroside-Sulfatase - genetics ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Errors of metabolism ; Gene Frequency ; General aspects. Genetic counseling ; Genotype & phenotype ; genotype-phenotype correlations ; Heterozygote ; Humans ; Leukocytes ; Leukodystrophy, Metachromatic - epidemiology ; Leukodystrophy, Metachromatic - etiology ; Leukodystrophy, Metachromatic - genetics ; Lipids (lysosomal enzyme disorders, storage diseases) ; Medical genetics ; Medical sciences ; Metabolic diseases ; metachromatic leukodystrophy ; Molecular biology ; Mutation ; mutation analysis ; Neurology ; Patients ; Phenotype ; Poland</subject><ispartof>Clinical genetics, 2005-07, Vol.68 (1), p.48-54</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright Blackwell Publishing Jul 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4121-738dbc9240134e09f55b130d612f1b1430af2bdcfce89acd740f4c5687d8ab9d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1399-0004.2005.00451.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1399-0004.2005.00451.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16833124$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15952986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ługowska, A</creatorcontrib><creatorcontrib>Berger, J</creatorcontrib><creatorcontrib>Tylki-Szymańska, A</creatorcontrib><creatorcontrib>Löschl, B</creatorcontrib><creatorcontrib>Molzer, B</creatorcontrib><creatorcontrib>Zobel, M</creatorcontrib><creatorcontrib>Czartoryska, B</creatorcontrib><title>Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland</title><title>Clinical genetics</title><addtitle>Clin Genet</addtitle><description>The occurrence and genotype–phenotype correlations of the eight most common mutations in the arylsulfatase A (ARSA) gene were studied in 43 unrelated Polish patients suffering from different types of metachromatic leukodystrophy (MLD). Screening for mutations p.R84Q, p.S96F, c.459+1G>A, p.I179S, p.A212V, c.1204+1G>A, p.P426L, and c.1401–1411del allowed the identification of 53.5% of the mutant alleles. In the whole investigated group of patients, mutations c.459+1G>A and p.P426L were the most frequent, 19 and 17%, respectively. The prevalence of the third most frequent mutation, i.e. p.I179S (13%), seems to be higher than that in other populations. The incidence of c.1204+1G>A was 5%, which is higher than reported earlier (2%). It seems that p.I179S and c.1204+1G>A are more prevalent in MLD patients from Poland than from other countries. In the group examined by us, mutations p.R84Q, p.S96F, p.A212V, and c.1401–1411del were not detected; thus, 46.5% of MLD alleles remained unidentified. This indicates that other, novel or already described, but rare, mutations exist in Polish population. In late infantile homozygotes for c.459+1G>A and one homozygote for c.1204+1G>A, first clinical symptom was motor deterioration. In adult homozygotes for p.P426L, the disease onset manifested as gait disturbances, followed by choreoathetotic movements, difficulties in swallowing, dysarthria, tremor, and nystagmus. In the carriers of the p.I179S mutation, the hallmark of the clinical picture was psychotic disturbances.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age of Onset</subject><subject>Alleles</subject><subject>arylsulfatase A</subject><subject>Biological and medical sciences</subject><subject>Cerebroside-Sulfatase - deficiency</subject><subject>Cerebroside-Sulfatase - genetics</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Errors of metabolism</subject><subject>Gene Frequency</subject><subject>General aspects. Genetic counseling</subject><subject>Genotype & phenotype</subject><subject>genotype-phenotype correlations</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Leukocytes</subject><subject>Leukodystrophy, Metachromatic - epidemiology</subject><subject>Leukodystrophy, Metachromatic - etiology</subject><subject>Leukodystrophy, Metachromatic - genetics</subject><subject>Lipids (lysosomal enzyme disorders, storage diseases)</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>metachromatic leukodystrophy</subject><subject>Molecular biology</subject><subject>Mutation</subject><subject>mutation analysis</subject><subject>Neurology</subject><subject>Patients</subject><subject>Phenotype</subject><subject>Poland</subject><issn>0009-9163</issn><issn>1399-0004</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1v1DAQhi0EokvLX0AWEtwS_BE7scQFLSWlaqEHEBISshzH0WabxMFOxObfd7a7tFJ9mfHMM-PxvAhhSlIK58M2pVyphBCSpYwQkYIjaLp7hlYPiedoBUYlikp-gl7FuIUrz4V6iU6oUIKpQq7Qn2vfOTt3JmAz1HjcuMFPy9habDcmGDu50MaptRH7BvduMnYTfG8ggjs33_p6iVPw42bBIwTdMEXcAIBvfAf9ztCLxnTRvT7aU_Tzy_mP9UVy9b38uv50ldiMMprkvKgrq1hGKM8cUY0QFeWklpQ1tKIZJ6ZhVW0b6wplbJ1npMmskEVeF6ZSNT9F7w99x-D_zi5Oum-jdR3M4PwctcwVUyRnAL59Am79HAaYTcMec1JIKQB6c4Tmqne1HkPbm7Do_1sD4N0RMNGarglmsG185GTBOWUZcB8P3L-2c8tjnui9inqr92LpvVj714W-V1Hv9Lo8BwfKk0M5KOB2D-Um3MKHQEn961upy6K8uPwsf-tLfgc5g5-P</recordid><startdate>200507</startdate><enddate>200507</enddate><creator>Ługowska, A</creator><creator>Berger, J</creator><creator>Tylki-Szymańska, A</creator><creator>Löschl, B</creator><creator>Molzer, B</creator><creator>Zobel, M</creator><creator>Czartoryska, B</creator><general>Blackwell Publishing Ltd/Inc</general><general>Blackwell</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200507</creationdate><title>Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland</title><author>Ługowska, A ; Berger, J ; Tylki-Szymańska, A ; Löschl, B ; Molzer, B ; Zobel, M ; Czartoryska, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4121-738dbc9240134e09f55b130d612f1b1430af2bdcfce89acd740f4c5687d8ab9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age of Onset</topic><topic>Alleles</topic><topic>arylsulfatase A</topic><topic>Biological and medical sciences</topic><topic>Cerebroside-Sulfatase - deficiency</topic><topic>Cerebroside-Sulfatase - genetics</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Errors of metabolism</topic><topic>Gene Frequency</topic><topic>General aspects. Genetic counseling</topic><topic>Genotype & phenotype</topic><topic>genotype-phenotype correlations</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Leukocytes</topic><topic>Leukodystrophy, Metachromatic - epidemiology</topic><topic>Leukodystrophy, Metachromatic - etiology</topic><topic>Leukodystrophy, Metachromatic - genetics</topic><topic>Lipids (lysosomal enzyme disorders, storage diseases)</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>metachromatic leukodystrophy</topic><topic>Molecular biology</topic><topic>Mutation</topic><topic>mutation analysis</topic><topic>Neurology</topic><topic>Patients</topic><topic>Phenotype</topic><topic>Poland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ługowska, A</creatorcontrib><creatorcontrib>Berger, J</creatorcontrib><creatorcontrib>Tylki-Szymańska, A</creatorcontrib><creatorcontrib>Löschl, B</creatorcontrib><creatorcontrib>Molzer, B</creatorcontrib><creatorcontrib>Zobel, M</creatorcontrib><creatorcontrib>Czartoryska, B</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ługowska, A</au><au>Berger, J</au><au>Tylki-Szymańska, A</au><au>Löschl, B</au><au>Molzer, B</au><au>Zobel, M</au><au>Czartoryska, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland</atitle><jtitle>Clinical genetics</jtitle><addtitle>Clin Genet</addtitle><date>2005-07</date><risdate>2005</risdate><volume>68</volume><issue>1</issue><spage>48</spage><epage>54</epage><pages>48-54</pages><issn>0009-9163</issn><eissn>1399-0004</eissn><coden>CLGNAY</coden><abstract>The occurrence and genotype–phenotype correlations of the eight most common mutations in the arylsulfatase A (ARSA) gene were studied in 43 unrelated Polish patients suffering from different types of metachromatic leukodystrophy (MLD). Screening for mutations p.R84Q, p.S96F, c.459+1G>A, p.I179S, p.A212V, c.1204+1G>A, p.P426L, and c.1401–1411del allowed the identification of 53.5% of the mutant alleles. In the whole investigated group of patients, mutations c.459+1G>A and p.P426L were the most frequent, 19 and 17%, respectively. The prevalence of the third most frequent mutation, i.e. p.I179S (13%), seems to be higher than that in other populations. The incidence of c.1204+1G>A was 5%, which is higher than reported earlier (2%). It seems that p.I179S and c.1204+1G>A are more prevalent in MLD patients from Poland than from other countries. In the group examined by us, mutations p.R84Q, p.S96F, p.A212V, and c.1401–1411del were not detected; thus, 46.5% of MLD alleles remained unidentified. This indicates that other, novel or already described, but rare, mutations exist in Polish population. In late infantile homozygotes for c.459+1G>A and one homozygote for c.1204+1G>A, first clinical symptom was motor deterioration. In adult homozygotes for p.P426L, the disease onset manifested as gait disturbances, followed by choreoathetotic movements, difficulties in swallowing, dysarthria, tremor, and nystagmus. In the carriers of the p.I179S mutation, the hallmark of the clinical picture was psychotic disturbances.</abstract><cop>Oxford, UK; Malden, USA</cop><pub>Blackwell Publishing Ltd/Inc</pub><pmid>15952986</pmid><doi>10.1111/j.1399-0004.2005.00451.x</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9163 |
ispartof | Clinical genetics, 2005-07, Vol.68 (1), p.48-54 |
issn | 0009-9163 1399-0004 |
language | eng |
recordid | cdi_proquest_miscellaneous_67929072 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Adolescent Adult Age of Onset Alleles arylsulfatase A Biological and medical sciences Cerebroside-Sulfatase - deficiency Cerebroside-Sulfatase - genetics Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Errors of metabolism Gene Frequency General aspects. Genetic counseling Genotype & phenotype genotype-phenotype correlations Heterozygote Humans Leukocytes Leukodystrophy, Metachromatic - epidemiology Leukodystrophy, Metachromatic - etiology Leukodystrophy, Metachromatic - genetics Lipids (lysosomal enzyme disorders, storage diseases) Medical genetics Medical sciences Metabolic diseases metachromatic leukodystrophy Molecular biology Mutation mutation analysis Neurology Patients Phenotype Poland |
title | Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A32%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20and%20phenotypic%20characteristics%20of%20metachromatic%20leukodystrophy%20patients%20from%20Poland&rft.jtitle=Clinical%20genetics&rft.au=%C5%81ugowska,%20A&rft.date=2005-07&rft.volume=68&rft.issue=1&rft.spage=48&rft.epage=54&rft.pages=48-54&rft.issn=0009-9163&rft.eissn=1399-0004&rft.coden=CLGNAY&rft_id=info:doi/10.1111/j.1399-0004.2005.00451.x&rft_dat=%3Cproquest_pubme%3E67929072%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200708665&rft_id=info:pmid/15952986&rfr_iscdi=true |